Product Information
ATIVAN 2 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $75.9602 per EA under NDC 00187006501. Its NADAC has been published 199 times since Feb 12, 2014.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lorazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Bausch Health US LLCNDC
00187006501
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/1/2025
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA017794FDA Approved
Before 1982
TE Code
AB
On Market Since
5/1/2013
Pharmacological Classes
Price Statistics
The NADAC for ATIVAN 2 MG TABLET has been published 199 times since Feb 12, 2014, and over the history we have for it it has risen 605.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $75.9602 per EA |
|---|---|
| All-time high | $75.9602 (Oct 1, 2025) |
| All-time low | $10.7734 (Feb 12, 2014) |
| 52-week high | $75.9602 |
| 52-week low | $75.9602 |
| Median price | $40.3975 |
| Average price | $44.2747 |
| Largest weekly change | +73.9% (Jun 19, 2024) |
| Weeks tracked | 199 |
| Tracking since | Feb 12, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+88.0%
5Y
+88.0%
All
+605.1%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lorazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATIVAN 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATIVAN 2 MG TABLET, manufactured by Bausch Health US LLC, is $75.9602 per EA (NDC 00187006501), effective Oct 1, 2025.
How has the price of ATIVAN 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATIVAN 2 MG TABLET has risen 605.1%. It has been tracked across 199 weekly CMS publications since Feb 12, 2014.
What are the highest and lowest recorded NADAC prices for ATIVAN 2 MG TABLET?
Since Feb 12, 2014, the NADAC for ATIVAN 2 MG TABLET has ranged from a low of $10.7734 (Feb 12, 2014) to a high of $75.9602 (Oct 1, 2025), with a median of $40.3975 per EA.
Are there cheaper alternatives to ATIVAN 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ATIVAN 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ATIVAN 2 MG TABLET?
ATIVAN 2 MG TABLET (NDC 00187006501) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.